BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26647925)

  • 1. Identifying molecular subtypes in human colon cancer using gene expression and DNA methylation microarray data.
    Ren Z; Wang W; Li J
    Int J Oncol; 2016 Feb; 48(2):690-702. PubMed ID: 26647925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of DNA methylation in 3' genomic regions that are associated with upregulation of gene expression in colorectal cancer.
    Smith JF; Mahmood S; Song F; Morrow A; Smiraglia D; Zhang X; Rajput A; Higgins MJ; Krumm A; Petrelli NJ; Costello JF; Nagase H; Plass C; Held WA
    Epigenetics; 2007 Sep; 2(3):161-72. PubMed ID: 17965620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colon Cancer Tumor Location Defined by Gene Expression May Disagree With Anatomic Tumor Location.
    Cannon E; Buechler S
    Clin Colorectal Cancer; 2019 Jun; 18(2):149-158. PubMed ID: 30853326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers.
    Cheng J; Wei D; Ji Y; Chen L; Yang L; Li G; Wu L; Hou T; Xie L; Ding G; Li H; Li Y
    Genome Med; 2018 May; 10(1):42. PubMed ID: 29848370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.
    Marisa L; de Reyniès A; Duval A; Selves J; Gaub MP; Vescovo L; Etienne-Grimaldi MC; Schiappa R; Guenot D; Ayadi M; Kirzin S; Chazal M; Fléjou JF; Benchimol D; Berger A; Lagarde A; Pencreach E; Piard F; Elias D; Parc Y; Olschwang S; Milano G; Laurent-Puig P; Boige V
    PLoS Med; 2013; 10(5):e1001453. PubMed ID: 23700391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival differences of CIMP subtypes integrated with CNA information in human breast cancer.
    Wang H; Yan W; Zhang S; Gu Y; Wang Y; Wei Y; Liu H; Wang F; Wu Q; Zhang Y
    Oncotarget; 2017 Jul; 8(30):48807-48819. PubMed ID: 28415743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermediate- and low-methylation epigenotypes do not correspond to CpG island methylator phenotype (low and -zero) in colorectal cancer.
    Karpinski P; Walter M; Szmida E; Ramsey D; Misiak B; Kozlowska J; Bebenek M; Grzebieniak Z; Blin N; Laczmanski L; Sasiadek MM
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):201-8. PubMed ID: 23175427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular subtypes of glioma identified by genome-wide methylation profiling.
    Kloosterhof NK; de Rooi JJ; Kros M; Eilers PH; Sillevis Smitt PA; van den Bent MJ; French PJ
    Genes Chromosomes Cancer; 2013 Jul; 52(7):665-74. PubMed ID: 23629961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer.
    Shen L; Toyota M; Kondo Y; Lin E; Zhang L; Guo Y; Hernandez NS; Chen X; Ahmed S; Konishi K; Hamilton SR; Issa JP
    Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18654-9. PubMed ID: 18003927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer.
    Ichimura N; Shinjo K; An B; Shimizu Y; Yamao K; Ohka F; Katsushima K; Hatanaka A; Tojo M; Yamamoto E; Suzuki H; Ueda M; Kondo Y
    Cancer Prev Res (Phila); 2015 Aug; 8(8):702-11. PubMed ID: 26063725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA sequencing and Immunohistochemistry Reveal
    Esteve-Codina A; Alameda F; Carrato C; Pineda E; Arpí O; Martinez-García M; Mallo M; Gut M; Dabad M; Tortosa A; Del Barco S; Capellades J; Puig J; Gallego O; Pujol T; Oleaga L; Gil-Gil M; de Quintana-Schmidt C; Valduvieco I; Martinez-Cardús A; Bellosillo B; Muñoz-Marmol AM; Esteve A; Domenech M; Camins A; Craven-Bartle J; Villa S; Marruecos J; Domenech S; de la Iglesia N; Balana C
    Clin Cancer Res; 2021 Jan; 27(2):645-655. PubMed ID: 33106291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relational analysis of CpG islands methylation and gene expression in human lymphomas using possibilistic C-means clustering and modified cluster fuzzy density.
    Sjahputera O; Keller JM; Davis JW; Taylor KH; Rahmatpanah F; Shi H; Anderson DT; Blisard SN; Luke RH; Popescu M; Arthur GC; Caldwell CW
    IEEE/ACM Trans Comput Biol Bioinform; 2007; 4(2):176-89. PubMed ID: 17473312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
    Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
    PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a CpG island methylator phenotype in adrenocortical carcinomas.
    Barreau O; Assié G; Wilmot-Roussel H; Ragazzon B; Baudry C; Perlemoine K; René-Corail F; Bertagna X; Dousset B; Hamzaoui N; Tissier F; de Reynies A; Bertherat J
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E174-84. PubMed ID: 23093492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multilevel omic data clustering reveals variable contribution of methylator phenotype to integrative cancer subtypes.
    Karpinski P; Patai AV; Hap W; Kielan W; Laczmanska I; Sasiadek MM
    Epigenomics; 2018 Oct; 10(10):1289-1299. PubMed ID: 29896967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular subtypes based on DNA methylation predict prognosis in colon adenocarcinoma patients.
    Yang C; Zhang Y; Xu X; Li W
    Aging (Albany NY); 2019 Dec; 11(24):11880-11892. PubMed ID: 31852837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining the effect of DNA methylation on gene expression in cancer cells.
    Lee CJ; Evans J; Kim K; Chae H; Kim S
    Methods Mol Biol; 2014; 1101():161-78. PubMed ID: 24233782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-CpG island recovery assay and identification of their expression levels.
    Lian ZQ; Wang Q; Li WP; Zhang AQ; Wu L
    Int J Oncol; 2012 Aug; 41(2):629-38. PubMed ID: 22581028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring breast carcinogenesis through integrative genomics and epigenomics analyses.
    Minning C; Mokhtar NM; Abdullah N; Muhammad R; Emran NA; Ali SA; Harun R; Jamal R
    Int J Oncol; 2014 Nov; 45(5):1959-68. PubMed ID: 25175708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rectal cancer profiling identifies distinct subtypes in India based on age at onset, genetic, epigenetic and clinicopathological characteristics.
    Laskar RS; Ghosh SK; Talukdar FR
    Mol Carcinog; 2015 Dec; 54(12):1786-95. PubMed ID: 25418895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.